Mar 29, 2022 / 12:00PM GMT
Operator
Good day, and thank you for standing by. Welcome to the IGM-Sanofi Collaboration Agreement Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to Fred Schwarzer, Chief Executive Officer. Please go ahead, sir.
Fred M. Schwarzer - IGM Biosciences, Inc. - CEO, President & Director
Thank you, operator, and welcome to all of you for joining us on this call. I'm joined today by Misbah Tahir, Chief Financial Officer; Dr. Chris Takimoto, Chief Medical Officer; and Dr. Mary Beth Harler, President, IGM Autoimmunity and Inflammation.
We're excited to share with you more information on the collaboration and license agreement with Sanofi which was announced today. This collaboration will involve multiple targets in oncology, autoimmunity and inflammation, and expands our research and development pipeline. We're very pleased to be working with such an experienced and strong partner as Sanofi. They have repeatedly demonstrated their
IGM Biosciences Inc to Discuss Global Collaboration Agreement with Sanofi - Conference Call Transcript
Mar 29, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers